Convergent Dental

Convergent Dental

Convergent Dental develops a computer-guided, laser-based drilling and cutting system for dentists.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
investor

€0.0

round
investor investor

€0.0

round
N/A

€0.0

round
investor investor investor

€0.0

round
N/A

€0.0

round
investor

€0.0

round
investor investor

€0.0

Valuation: €0.0

round
*
N/A

$5.0m

Convertible
Total Funding000k
Notes (0)
More about Convergent Dental
Made with AI
Edit

Convergent Dental, Inc. operates as a privately held dental equipment and technology company, having been founded by Michael Cataldo in 2011 with the objective of addressing patient fear of dental procedures. Cataldo, a serial entrepreneur with a background in healthcare software, previously founded MediVation, which was later acquired by McKesson. After years of development, the company introduced its flagship product in 2013. Robert L. Gershon, a seasoned executive in the medical technology sector with prior leadership roles at companies like Mauna Kea Technologies and Bovie Medical, took over as CEO in July 2022 following Cataldo's retirement.

The company's core business is the sale of its Solea® All-Tissue Dental Laser system to dental professionals, including solo practitioners, dental service organizations (DSOs), and dental schools. This system is designed to improve practice efficiency, clinical outcomes, and the overall patient experience. Revenue is generated through the sale of the Solea system, with the company also offering training, education programs, and customer support to ensure effective implementation. Strategic partnerships with distributors like Patterson Dental expand the company's market reach across the United States and Canada.

Solea is a computer-aided carbon dioxide (CO2) laser system distinguished by its unique 9.3-micron wavelength, which is highly absorbed by both hydroxyapatite (enamel) and water (soft tissue). This allows the laser to vaporize enamel and ablate soft and osseous tissue with high speed and precision, a key differentiator from other laser technologies that may slowly chip enamel or are limited to soft tissue applications. It is the only CO2 laser cleared by the FDA for all-tissue indications. For dentists, this translates to performing a wide array of procedures—from cavity preparations and gum contouring to treating snoring—often without the need for anesthetic injections, drills, or sutures. This capability enables dentists to perform more same-day and multi-quadrant procedures, significantly boosting practice productivity. For patients, the experience is quieter and avoids the vibration of a drill, reducing anxiety and discomfort. The system also includes a non-surgical treatment for palatal snoring, Solea® Sleep, which works by tightening tissue in the soft palate in a simple five-minute procedure.

Keywords: dental laser, all-tissue laser, Solea, CO2 laser, anesthesia-free dentistry, needle-free dentistry, pain-free dentistry, dental technology, medical device, hard and soft tissue laser, Michael Cataldo, Robert L. Gershon, Solea Sleep, snoring treatment, dental equipment, practice efficiency, patient experience, minimally invasive dentistry, periodontal treatment, Patterson Dental, Arboretum Ventures

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo